Pluristem Therapeutics Inc. (PSTI)

3.21
0.06 1.80
NASDAQ
Prev Close 3.27
Open 3.25
Day Low/High 3.21 / 3.28
52 Wk Low/High 2.82 / 13.29
Volume 43.56K
Exchange NASDAQ
Shares Outstanding 31.74B
Market Cap 105.69M
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Pluristem, Capricor Lead Regenerative Space Says Raymond James Analyst

Pluristem, Capricor Lead Regenerative Space Says Raymond James Analyst

Fate Therapeutics (FATE) is developing several small molecules which modulate umbilical cord stem cells.

Pluristem CEO Seeing the Future in 3D Cells

Pluristem CEO Seeing the Future in 3D Cells

Pluristem's successful stem cell trial last week on muscle injuries is an important first step for the company, says the company's CEO Zami Aberman.